Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. prepare

PREPARE SIGNED

Preventing Respiratory Events through Proactive Assessment of Respiratory Effort

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 PREPARE project word cloud

Explore the words cloud of the PREPARE project. It provides you a very rough idea of what is the project "PREPARE" about.

million    opportunity    rc    multinational    60m    monitoring    rr    globally    team    capture    hospitals    irish    undertaking    artifact    mou    ward    7    pmd    accurate    16    grow    allyn    optimisation    respiratory    ge    memorandum    validated    gt    continents    business    length    population    107    save    reject    distributor    settings    welch    marketing    25    trl7    intermediate    120    775m    prospects    patients    sales    breathing    20    premier    solutions    first    monitor    2019    companies    500    america    70    distributors    intervention    adoption    world    2020    21    generation    respirasense    ce    annual    rate    31bn    intensive    sustain    market    stay    5    care    mindray    30    platform    total    postoperative    admissions    negotiations    4    liabilities    asian    compromise    197    vp    continuous    hospital    400    clinical    10    marked    patient    asia    differentiated    event    countries    investigations    unplanned    incidence    medical    mortality   

Project "PREPARE" data sheet

The following table provides information about the project.

Coordinator		 PMD DEVICE SOLUTIONS LIMITED 

Organization address
address: BISHOPSTOWN HOUSE MODEL FARM ROAD
city: CORK
postcode: T12T922
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Ireland [IE]
 Project website http://www.pmd-solutions.com/
 Total cost 4˙265˙610 €
 EC max contribution 4˙265˙610 € (100%)
 Programme 1. H2020-EU.3.1. (SOCIETAL CHALLENGES - Health, demographic change and well-being)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-2-2015
 Funding Scheme SME-2
 Starting year 2016
 Duration (year-month-day) from 2016-04-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PMD DEVICE SOLUTIONS LIMITED IE (CORK) coordinator 4˙265˙610.00

Map

 Project objective

The incidence rate of Respiratory Compromise (RC) in hospital settings is 7% in intermediate/general care ward patients (107 million patients) and 30% in step-down postoperative patients (197 Million patients), at an average cost of €16,500 per event. It will cost the EU €31Bn by 2019. PMD’s technology will lead to a 20% reduction in the average patient length of stay, a 10% reduction in unplanned intensive care admissions, and a 5% reduction in liabilities from patient mortality by enabling early intervention of Respiratory Compromise (RC). This will be achieved by enabling the continuous and accurate monitoring of general ward patients respiratory rate (70% of the total patient population). The business opportunity is PMD Solutions (PMD), with its unique respiratory monitoring platform technology and its premier TRL7 CE marked product RespiraSense - the world’s first continuous respiratory rate monitor that is highly differentiated due to its ability to reject non-breathing artifact. This proposal, through the undertaking of clinical investigations, product optimisation, new product development and sales and marketing, will enable PMD to capture 0.4% of the market and sustain a 400% annual growth rate by 2020. It will lead to the generation of >€60M with sales across 3 continents including Europe, America and Asia and to grow the team from 10 to 21 within 3 years. PMD currently has 1 agreement with an Irish distributor and 7 Memorandum of Understanding (MoU) with other distributors across Europe with a further 25 other prospects. PMD is also in negotiations with the VP of marketing at each of the top 2 US (Welch Allyn, GE Medical) and the top Asian (Mindray) multinational patient monitoring companies. Globally hospital’s will save €775M over the next 3 years through their adoption of continuous monitoring of respiratory rate (RR). The unique technology platform has been validated on over 120 patients across 5 clinical areas in 5 hospitals, across 5 countries.

 Deliverables

List of deliverables.
PR collateral Websites, patent fillings, videos etc. 2019-05-31 16:50:40

Take a look to the deliverables list in detail:  detailed list of PREPARE deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREPARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREPARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.;H2020-EU.2.3.1.)

PREPARE (2016)

Preventing Respiratory Events through Proactive Assessment of Respiratory Effort

Read More  

ADVANTAGE (2015)

ADvanced Validation of A Novel TB Active disease diagnostic to address Global unmet needs: a European consortium approach

Read More  

LASER-HISTO (2016)

In vivo histology using femtosecond laser multiphoton tomograph for the early diagnosis of skin cancer and corneal diseases while simultaneously reducing Europe’s health care costs

Read More